Clinical Neuropharmacology

Papers
(The TQCC of Clinical Neuropharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Effectiveness and Safety of Early High-Efficacy Versus Escalation Therapy in Relapsing-Remitting Multiple Sclerosis in Argentina14
Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature13
Comparison of Amantadine, Modafinil, and Standard of Care in the Acute Treatment of Disorders of Consciousness After Severe Traumatic Brain Injury11
Misophonia Successfully Treated of With Fluoxetine: A Case Report11
Behavioral and Cognitive Response to Selective Serotonin Reuptake Inhibitors in Frontotemporal Lobar Degeneration: A Systematic Review and Meta-analysis10
A Systematic Review of Seizure-Freedom Rates in Patients With Benign Epilepsy of Childhood With Centrotemporal Spikes Receiving Antiepileptic Drugs10
β-Blockers for the Treatment of Misophonia and Misokinesia9
The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies7
Long-Term Benzodiazepine Prescription During Maintenance Therapy of Individuals With Psychosis Spectrum Disorders—Associations With Cognition and Global Functioning7
Comparative Analysis of the Effects of Escitalopram, Pramipexole, and Transcranial Magnetic Stimulation on Depression in Patients With Parkinson Disease: An Open-Label Randomized Controlled Trial6
Efficacy and Safety of Intranasal Dexmedetomidine During Recovery From Sevoflurane Anesthesia in Children: A Systematic Review and Meta-analysis6
Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin6
The Efficacy of Dendritic Cell Vaccine for Newly Diagnosed Glioblastoma: A Meta-analysis of Randomized Controlled Studies6
Levosulpiride Relieved Persistent Hiccups in a Patient With COVID-19 and Vascular Cognitive Impairment6
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal5
Gabapentin-Induced Myokymia: A Case Report5
Metronidazole-Induced Toxic Neuropathy With the “Boomerang” Sign5
Clozapine Use in a Movement Disorder Clinic5
Atomoxetine Reduced Binge/Purge Symptoms in a Case of Anorexia Nervosa Binge/Purge Type5
Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder5
Seizure Occurring During Baclofen Monotherapy for Phenibut Withdrawal5
Late Presentation of Linezolid-Induced Serotonin Syndrome After Maprotiline and Mirtazapine Therapy: A Case Report5
Flumazenil for Successful Seizure Induction With Electroconvulsive Therapy: Case Report and Literature Review4
Successful Use of Minocycline for the Treatment of Methamphetamine-Induced Psychosis and Cognitive Impairments: An Open-Label Case Series4
Severe Demyelinating Polyneuropathy and Cranial Neuropathy During Avelumab Treatment of Metastatic Merkel Cell Carcinoma4
Medical Cannabis in the Treatment of Parkinson’s Disease4
Effects of Rivastigmine on Brain Functional Networks in Patients With Alzheimer Disease Based on the Graph Theory4
Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: A Meta-Analysis of Randomized Controlled Trials4
Clozapine-Induced Fever and Plasma Cytokine Changes in a Patient With Schizophrenia4
QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome4
Lithium-Induced Treatment-Resistant Akathisia: A Case Report and Literature Overview4
Intravenous Lacosamide in Seizure Clusters: Dose and Efficacy4
The Pharmacotherapeutic Landscape for Essential Tremor: Quantifying the Level of Unmet Need From a Patient and Epidemiologic Perspective4
Resveratrol Treatment of Autism Spectrum Disorder—A Pilot Study4
The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study4
Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids4
Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study3
Functional Improvement of Tacrolimus-Induced Parkinsonism With Amantadine After Liver Transplantation: A Case Report3
Effect of Adding l-Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Tri3
Perampanel-Induced Psychosis in a Young Woman: A Case Report3
Probable Methylphenidate-Related Reversible “Visual Snow” in a Child With ADHD3
Methylphenidate-Induced Enuresis: 3 Case Reports3
Effects of Exercise on Testosterone and Implications of Drug Abuse: A Review3
The Clinical Development of Levodopa Inhalation Powder3
Intravenous Immunoglobulin in the Treatment of Alternating Hemiplegia of Childhood3
The Downside of Botulinum Injections for Anterocollis: A Case Series and a Review of the Literature3
Fluoxetine-induced Systemic Hypertension in a 12-Year-Old Girl: A Case Report3
Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Cas3
Absolute Agranulocytosis After 9 Weeks of Clozapine 25 mg Daily3
Effectiveness and Safety of Memantine for Headache: A Meta-analysis of Randomized Controlled Studies3
Clozapine-Associated Pisa Syndrome: A Case Report of an Acute Reaction in a Bipolar Patient3
Oculogyric Crisis Due to Low-Dose Olanzapine: A Case Report3
The Effects of Ibuprofen Consumption on the Incidence of Postpartum Depression3
The Effect of Epilepsy and Antiepileptic Drugs on Cortical Motor Excitability in Patients With Temporal Lobe Epilepsy3
Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia3
Severe Relapses of Neuromyelitis Optica Spectrum Disorder During Treatment With Dimethyl Fumarate3
0.026291847229004